Plasmodium vivax elimination from India may need therapeutic efficacy studies - Informed shift to artemisinin-based treatment
{{output}}
India has significantly reduced its Plasmodium vivax (P. vivax, Pv) malaria burden. However, threat of chloroquine (CQ) resistance can undermine these gains. Artemisinin-based combination therapies (ACTs) have demonstrated superior efficacy compared to CQ, par... ...
